Remi Gaston-Dreyfus - Jul 15, 2021 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Stock symbol
BNKL
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
4
Date filed
12/13/2021, 03:32 PM
Previous filing
Dec 13, 2021
Next filing
Jun 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Options Exercise +116K +7.82% 1.6M Jul 15, 2021 Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA F1
transaction BNKL Common Stock, par value $0.001 per share Options Exercise +5K +0.31% 1.6M Jul 15, 2021 Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA F1
holding BNKL Common Stock, par value $0.001 per share 61.3K Jul 15, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNKL Stock Option (right to buy) Options Exercise $0 -116K -100% $0.00* 0 Jul 15, 2021 Common Stock, par value $0.001 per share 116K $3.60 Direct
transaction BNKL Stock Option (right to buy) Options Exercise $0 -5K -100% $0.00* 0 Jul 15, 2021 Common Stock, par value $0.001 per share 5K $3.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Payment of exercise price was satisfied through the satisfaction of an Issuer promissory note held by the Reporting Person.
F2 The options vested 1,666 on May 31, 2019, 1,666 on November 30, 2019 and 1,668 on May 31, 2020.